France · Delayed Price · Currency is EUR IntegraGen Statistics
Total Valuation
IntegraGen has a market cap or net worth of EUR 1.01 million. The enterprise value is -297,653.
| Market Cap | 1.01M |
| Enterprise Value | -297,653 |
Important Dates
The next estimated earnings date is Thursday, April 23, 2026.
| Earnings Date | Apr 23, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
IntegraGen has 6.62 million shares outstanding.
| Current Share Class | 6.62M |
| Shares Outstanding | 6.62M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.15 |
| PB Ratio | 2.89 |
| P/TBV Ratio | 2.89 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 0.19 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.19, with a Debt / Equity ratio of 1.20.
| Current Ratio | 1.19 |
| Quick Ratio | 1.10 |
| Debt / Equity | 1.20 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -138.00% and return on invested capital (ROIC) is -213.99%.
| Return on Equity (ROE) | -138.00% |
| Return on Assets (ROA) | -23.72% |
| Return on Invested Capital (ROIC) | -213.99% |
| Return on Capital Employed (ROCE) | -240.65% |
| Weighted Average Cost of Capital (WACC) | 4.51% |
| Revenue Per Employee | 165,200 |
| Profits Per Employee | -38,700 |
| Employee Count | 40 |
| Asset Turnover | 1.34 |
| Inventory Turnover | 19.35 |
Taxes
| Income Tax | -99,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -74.45% in the last 52 weeks. The beta is 0.39, so IntegraGen's price volatility has been lower than the market average.
| Beta (5Y) | 0.39 |
| 52-Week Price Change | -74.45% |
| 50-Day Moving Average | 0.15 |
| 200-Day Moving Average | 0.29 |
| Relative Strength Index (RSI) | 57.86 |
| Average Volume (20 Days) | 7,401 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, IntegraGen had revenue of EUR 6.61 million and -1.55 million in losses.
| Revenue | 6.61M |
| Gross Profit | 768,000 |
| Operating Income | -1.87M |
| Pretax Income | -1.65M |
| Net Income | -1.55M |
| EBITDA | -1.83M |
| EBIT | -1.87M |
| Earnings Per Share (EPS) | n/a |
Balance Sheet
The company has 1.72 million in cash and 417,000 in debt, with a net cash position of 1.30 million or 0.20 per share.
| Cash & Cash Equivalents | 1.72M |
| Total Debt | 417,000 |
| Net Cash | 1.30M |
| Net Cash Per Share | 0.20 |
| Equity (Book Value) | 348,000 |
| Book Value Per Share | n/a |
| Working Capital | 549,000 |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 11.62%, with operating and profit margins of -28.22% and -23.43%.
| Gross Margin | 11.62% |
| Operating Margin | -28.22% |
| Pretax Margin | -24.92% |
| Profit Margin | -23.43% |
| EBITDA Margin | -27.63% |
| EBIT Margin | -28.22% |
| FCF Margin | n/a |
Dividends & Yields
IntegraGen does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -153.82% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |